Join Vumedi Select specialty Your main specialty Adult & Family Medicine Allergy, Asthma, Immunology Anesthesiology Cardiology Dental Dermatology Emergency Medicine Endocrinology Gastroenterology & Hepatology General Surgery Hematology & Oncology Infectious Disease Medical Genetics Nephrology Neurology Neurosurgery Obstetrics/Gynecology Ophthalmology Oral Maxillofacial Orthopaedics Otolaryngology Pathology Pediatrics Physical Medicine & Rehab Plastic Surgery Podiatry Preventive Medicine Psychiatry Pulmonology Radiation Oncology Radiology Rheumatology Urology First name Last name Email Choose Password
doi:10.1161/STROKEAHA.107.484162
Potential for pharmacological intervention in Werner syndrome
Additional specific drugs and compounds of interest from which the drug moiety may be derived include, but are not limited to: Central nervous system depressants: general anesthetics (barbiturates, benzodiazepines, steroids, cyclohexanone derivatives, and miscellaneous agents), sedative-hypnotics (benzodiazepines, barbiturates, piperidinediones and triones, quinazoline derivatives, carbamates, aldehydes and derivatives, amides, acyclic ureides, benzazepines and related drugs, phenothiazines, etc.), central voluntary muscle tone modifying drugs (anticonvulsants, such as hydantoins, barbiturates, oxazolidinediones, succinimides, acylureides, glutarimides, benzodiazepines, secondary and tertiary alcohols, dibenzazepine derivatives, valproic acid and derivatives, GABA analogs, etc.), analgesics (morphine and derivatives, oripavine derivatives, morphinan derivatives, phenylpiperidines, 2,6-methane-3-benzazocaine derivatives, diphenylpropylamines and isosteres, salicylates, p-aminophenol derivatives, 5- pyrazolone derivatives, arylacetic acid derivatives, fenamates and isosteres, naltrexone, methylnaltrexone, etc.) and antiemetics (anticholinergics, antihistamines, antidopaminergics, etc.), analgesic agents as disclosed in U
